A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Eli Lilly and Company
Massachusetts General Hospital
Kedrion S.p.A.
Ossium Health, Inc.
Orca Biosystems, Inc.
Nantes University Hospital
Stanford University
Zhejiang University
University of Colorado, Denver
Massachusetts General Hospital
Dana-Farber Cancer Institute
Kelonia Therapeutics, Inc.
Zhejiang University
University of Southern California
Azienda USL Reggio Emilia - IRCCS
Cogent Biosciences, Inc.
Cellenkos, Inc.
University Hospital Bispebjerg and Frederiksberg
Universitair Ziekenhuis Brussel